ArticleEndocrine-related cancer2013

IL6 sensitizes prostate cancer to the antiproliferative effect of IFNα2 through IRF9.

Holger H H Erb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.